Abstract: Ceruloplasmin Oxidase Activity as a Biomarker of Lead Exposure: Warin LEELAKUNAKORN, et al. Department of Pathology, Faculty of Medicine, Mahidol University, Thailand-The most sensitive method used in monitoring the blood lead-level is atomic absorption spectrophotometry. Its limitation due to its high cost has made delta-aminolaevulinic acid dehydratase (δ-ALAD) inhibition more popular. This work demonstrates that ceruloplasmin (Cp), the bluecolored copper containing alpha-2 globulin (α 2 globulin) glycoprotein in serum, can serve as a high-potential biomarker for lead exposure. Sephadex G-200 column chromatography demonstrated that lead-intoxicated patient serum transferrin and ceruloplasmin are bound to lead. The ceruloplasmin's oxidase and δ-ALAD activities are reduced when the blood-lead level increases (thresholds of 10.0 and 12.5 µg/100 mL respectively), with a correlation coefficient of -0.8643 and -0.6785 which accurately estimate a blood lead level of 74.7% and 46.0%, respectively. When the blood-lead level was less than 20 µg/100 mL, correlation coefficients of -0.5785 and -0.6963 suggested that Cp may serve as a good biomarker. Other advantages in using Cp in monitoring the bloodlead level were its stability: the enzyme was more stable at -20°C, for more than 2 wk, and its practical and rapid determination procedure. (J Occup Health 2005; 47: 56-60) Key words: Lead, Ceruloplasmin, Oxidase activity Lead (Pb) has been one of the most useful metals mined and worked by men for millennia 1) . The main use of Pb is in the manufacture of batteries, in the chemical industry, and in the manufacture and handling of sulfuric acid, etc.
poisoning in humans.
Apart from acute Pb poisoning, Pb can also have chronic effects. In general, the symptoms are mainly neuromuscular, renal failure and brain damage 3) . In blood, the most obvious effect of Pb is the decrease in heme synthesis, which subsequently leads to anemia. Several enzymes playing an important role in heme synthesis are affected by Pb, for example, heme synthetase, deltaaminolaevulinic acid dehydrtase (δ -ALAD), ferrochelatase, delta-amino-laevulinic acid synthetase (δ-ALAS), uroporphyrinogen decarboxylase and coproporphyrinogen oxidase 2) . Determination of the blood Pb level alone cannot indicate the toxicity of Pb, since each individual has different degrees of tolerance of Pb 4) . Moreover, atomic absorption spectrophotometry required for the determination of Pb is an expensive method: the instrument is available only in specialist laboratories, and can be operated only by a well-trained technician. For these reasons, some Pb-affected enzymes have been used as biomarkers in monitoring Pb toxicity. Among these, δ-ALAD is the most popular one, and in some cases its result are analyzed in combination with the blood Pb level determined by atomic absorption spectrophotometry.
Besides the blood-Pb level and heme-synthesizing enzymes, other serum proteins exposed to Pb in the circulation may also serve as an important biomarker for Pb. This project demonstrates that ceruloplasmin (Cp), the blue-colored copper containing alpha-2 globulin (α 2 globulin) glycoprotein in serum, can serve as a highpotential biomarker for Pb. The physiological function of Cp as an enzyme is somewhat less well known, but recent reports indicate that this protein may have an important biological function as an enzyme. As a ferroxidase, Cp converts the reduced ferrous iron to oxidized ferric irons, and the results reported by several authors indicate that Cp facilitates the movement of iron from the cells to the blood 5) . There is increasing experimental evidence that Cp can also function as a superoxide dismutase, and can eventually function as an extracellular protective enzyme of superoxide radicals. This project demonstrated that Cp from Pb-intoxicated serum possessed Pb in its molecule. The bound Pb caused a reduction in Cp oxidase activity with a strong correlation between the blood-Pb level and ceruloplasmin's oxidase activity. Cp can therefore be utilized as a high-potential biomarker for Pb.
Methods

Subjects
Pb-intoxicated blood for chromatographic study was collected from a male patient, 40 yr of age whose blood Pb level was 40 µg/L. This was compared to that from a normal male person of the same age. The subjects of the population study were classified into three groups on the basis of different exposure to Pb.
Group I (N=21) represented the "normal" urban population. Subjects were 4 males and 17 females, randomly selected from students who had no occupational contact with Pb. The range of age in group I was 21-35 yr, with an average age of 28.5 yr.
Group II (N=12) represented slight to moderate exposure to Pb. The subjects were randomly selected from workers in a printing shop. This group contained 9 males and 3 females, with an average age of 31.8 yr, ranging from 26 to 42 yr.
Group III (N=20) The subjects were randomly selected from workers in battery factories, representing the most heavily Pb exposed group. This group contained 20 males with an average age of 32.2 yr, ranging from 21 to 40 yr.
Samplings
Blood samples were drawn from the cubital vein and transferred into two separate heparinized tubes (15 U/ mL) that were pre-soaked in 30% nitric acid overnight and rinsed 5 times with deionized water. The first tube for ceruloplasmin oxidase activity was centrifuged at 3,000 rpm for 10 min and the serum was assayed within 24 h. The second tube was kept for Pb level determination which was done the next day.
Gel Filtration Chromatography
The column (1.8 × 120 cm) was equilibrated and operated with 0.01 M acetate buffer pH 6.0 at a constant flow rate of 20 mL/h. Sample size and fraction volumes were 2 mL each.
Analyses
Ceruloplasmin's Oxidase Activity: Standard human ceruloplasmin was purchased from the Sigma Chemical Company, St. Louis, U.S.A. The determination of ceruloplasmin oxidase activity as modified from Wolf P, et al was done by monitoring the oxidation of N,Ndimethyl-p-phenylenediamine (PPD) by light absorption at 530 nanometers 6) . The 1-mL assay volume was composed of 660 µL of 0.1 M acetate buffer, pH 6.0 and 320 µL of 0.43% PPD. The reaction was started with 20 µL serum. "Control" was with serum in the presence of 0.035% sodium azide.
The spectrophotometer was calibrated by the modified method of Houchin, by monitoring the absorption of Brandowski's base. The reagent was the product of PPD oxidation with hydrogen peroxide in ammonia solution. The Molar absorptivity (ε) obtained could be used to calculate the international units of oxidase activity in µ mole/10 min as follows:
Aminoleuvulinic acid dehydratase (δ-ALAD) Activity: The enzyme converts aminoleuvulinic acid to porphobillinogen which can be further developed to a color product with Erlich's reagent. The activity of the enzyme can then be detected by monitoring light absorbance at 555 nanometers.
The assay was done according to the method described by Burch HB and Siegel AL 7) . After the lysis of 200 µL of the whole blood with 1.3 mL of 0.2% Triton-X 100, 1 mL of 0.01 M aminoleuvulinic acid was added. The reaction was mixed thoroughy and immediately divided into 4 tubes with 0.5 mL in each. Two tubes were kept as a "control", and the others were incubated at 37°C for 1 h. The reactions were stopped with 0.5 mL of 0.02 M trichloroacetic acid. The acid was added to the "control" before incubation. The reactions were further centrifuged at 3,000 rpm for 15 min, and 0.5 mL of the supernatant was mixed with the same volume of Erlich's reagent. After a further 13 min of incubation, the reaction was immediately measured for light absorption at 555 nanometers. Hematocrit was also measured and used for calculation of the international units of ALA-D as follows:
Determination of the metal level: The blood Pb concentration was determined by graphite furnace atomic absorption spectrophotometry (GFAAS) with the method described by Jacobson et al. 8) Prior to the determination, blood cells were lysed with 0.20% Triton-X 100, dissolved in 0.8 M HNO 3 , and centrifuged at 9,500 rpm for 4 min. Ten microliters of supernatant were diluted with 15 microliters of 0.16 M HNO 3 and further analyzed by GFAAS.
In the determination of Cu and Pb levels from the chromatographic fractions which contained very small amounts of protein, the Triton-X 100-pretreated step was omitted. The solution was dissolved in 0.16 M HNO 3 and directly injected into the GFAAS.
A spectrophotometer was operated at 283.3 nm and 324.8 nm for Pb and Cu determination, respectively. At the peak height mode with a 0.5 nm slit width, the internal standards were included. The sample size for injection was 16 µL, 0.1 M H 3 PO 4 and palladiums were used as emulsifiers for Pb and Cu determination, respectively.
Result
Characterization of human serum Pb-binding proteins.
With Sephadex-G 200 gel filtration, Pb-intoxicated patient serum possessed at least three Pb-binding proteins, of different molecular weights (Fig. 1b) . Compared to the normal serum in Fig. 1a , it was found that the highmolecular weight protein eluted in the wash-off corresponded to Cu-binding activity in the control serum. Besides the Cu-binding activity, its large molecular weight suggested that this protein may be ceruloplasmin, the 150,000 dalton copper-transporting protein in human serum. The second eluted off Pb-binding protein may be transferrin, the Fe-binding protein. The Fe-binding activity was also evidenced in the peak II normal serum (data not shown). Figure 2 demonstrates the inhibitory effect of Pb on purified ceruloplasmin oxidase and δ-ALAD activities, the commonly used biomarker. It was shown that Pb could inhibit both enzymes in a similar fashion. The inhibition pattern was slightly more pronounced on the δ-ALAD activity, but the inhibition was not complete on both enzymes, about 45 percent activity still remained in the case of the Cp and about 30 percent in that of the δ-ALAD. Figure 3 shows the correlation between the inhibitory effect on both enzymes and the blood-Pb levels for 3 groups of people, namely, normal subjects and workers in the publishing and battery factories that represent slight to high exposure to Pb, respectively. The correlation patterns of both enzymes were quite similar, which suggests that Cp oxidase activity can also serve as a biomarker for Pb exposure as δ-ALAD. The results were also analyzed statistically with ANOVA, the analysis of variance. The results in Table 1 show that there was no significant difference in the blood Pb level among control and printing workers, but a difference existed among control and battery workers. The same finding was also demonstrated in δ-ALAD activity. All the three groups showed significant differences in Cp oxidase activity. The latter finding suggests that Cp would serve as a more sensitive biomarker for Pb exposure.
Effect of Pb on ceruloplasmin oxidase and δ-ALAD activity
δ-ALAD and Cp were also monitored for their stability. The results in Fig. 4 show that Cp was much more stable in storage and the oxidase activity was stable at any temperature tested for more than 16 d. δ-ALAD activity decreased on storage at all temperatures tested, and at 4°C it decreased to about 25% on day 7. The stability confirms the high potential of Cp as a biomarker for field tests.
Discussion
Pb has been reported previously to affect the Cp Level of airborne lead in exposed children living near a secondary lead smelting plant. The effect had a clearcut upward trend in blood 9) . This suggested the effect of Pb on the Cp expression level. Besides, this study demonstrated Pb binding and inactivating of the Cp on the activity level.
The presence of Pb on the serum Cp in Pb-intoxicated patients' blood ( Fig. 1 ) leads to two interesting notions. Firstly, beside the inhibition of heme synthesizing enzymes, Pb can also bind to Tf and Cp which may subsequently induce anemia, since Cp catalyzes the transport of iron to Tf, the essential step in heme synthesis. If the Cp level had been monitored in this study, one could have found an increase in the Cp level as well.
Of these two proteins, Cp may have the higher potential for serving as a biomarker for the Pb level, since this alpha-2 globulin (α 2 globulin) glycoprotein not only transported Cu, but also possessed the "ferrooxidase" which facilitated the binding of iron to transferrin 10) . Cu on the Cp molecule has been shown to be required for the oxidase activity 11) . Pb may then replace Cu on the Cp molecule and lead to the reduction of its oxidase activity.
Although other Pb-binding proteins were also found in Pb-intoxicated patients, the oxidase activity, easily and inexpensively measured, allows ceruloplasmin to serve as a high-potential biomarker in human serum. This is noteworthy when compared to the expense incurred in each method, and is 1:8:18 per assay, a common inexpensive instrument for Cp assay. Compared to δ-ALAD, the routinely used biomarker for Pb, Cp oxidase was inhibited by Pb to a comparable degree (Fig. 2) . This suggests that Cp may also serve as a biomarker. Although 7 atoms of Cu were demonstrated on the molecule of Cp, the binding and kinetic studies suggested that Pb specifically replaced Cu which is essential for oxidase activity on the molecule of transferrin (result not shown). The result for 53 serum samples of different blood-lead levels indicates a strong relationship between the Pb level and both enzyme activities, with r=-0.8643 for the δ-ALAD and r=-0.6785 for the Cp. Moreover, the threshold for Pb of both oxidase and δ-ALAD are merely at the same level, with half inhibition of 12.5 and 10 µg/dL, respectively. Both enzymes may then be used to predict the blood-lead level to 74.7 and 46.0% accuracy, respectively.
When comparing the blood-lead levels in the control, workers in the publishing and battery factories, it was found that the blood-lead levels of the control and publishing workers were lower than that of the battery factory workers (X=30.14 µg/dL), with 95% significance. The same result was found in δ-ALAD activity, but it differed in the Cp oxidase activity where the mean values varied in every group. Supported by the high stability of Cp, all these findings indicated that the oxidase can serve as one of the best markers for monitoring Pb in human serum.
